Tevogen Bio Secures $10M Grant Funding
Tevogen Bio (Nasdaq: TVGN), a clinical-stage immunotherapy biotech company, has secured up to $10 million in non-dilutive grant funding...
Silexion Shows Strong Tumor Reduction in Pancreatic Cancer Models
Silexion Therapeutics announced positive preclinical data for SIL-204, its RNAi therapeutic candidate targeting KRAS-driven cancers. The data validates systemic...
March Biosciences Gets FDA Orphan Drug for Lymphoma
March Biosciences received FDA orphan drug designation for MB-105, its CD5-targeted CAR-T cell therapy for relapsed/refractory CD5-positive T-cell lymphoma....
SAB Bio Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142
SAB Bio announced positive topline data from a Phase 1 trial of SAB-142, a human anti-thymocyte immunoglobulin being developed...
Positive Topline Results in 5-MeO-DMT Study for Alcohol Use Disorder
Atai Life Sciences announced positive topline results from a Phase 2a study of BPL-003, a synthetic intranasal 5-MeO-DMT formulation,...
Data Minimization: Balancing GDPR & Research Insights
Data minimization is one of the fundamental principles of the General Data Protection Regulation (GDPR), aimed at ensuring that...
Advancing Cancer Treatment with Nektar Therapeutics: Insights into NKTR-255
In this interview, we sit down with Mario Marcondes from Nektar Therapeutics to explore the advancements and potential of...
Eisai’s Innovative Bayesian Approach Accelerates Alzheimer’s Drug Approval
At the DPHARM conference, Eisai Inc. showcased their groundbreaking use of Bayesian methods to achieve accelerated approval for their...
Top 3 GDPR Compliance Questions in Clinical Trials
In the fast-evolving world of clinical trials, GDPR compliance is more than a legal obligation—it’s a pillar of trust,...
Oncomatryx Secures €25M to Advance OMTX705 Clinical Trials
Oncomatryx, a biopharmaceutical company developing antibody-drug conjugates (ADCs), secured €25 million to advance clinical trials of OMTX705, a first-in-class...